Literature DB >> 14656458

An alternative genetic method to test essential vaccinia virus early genes.

Sayuri E M Kato1, Frederico A B Greco, Clarissa R A Damaso, Richard C Condit, Nissin Moussatché.   

Abstract

The vaccinia virus F11L gene product was identified during search for additional factors involved in the control of post-replicative viral gene transcription elongation. F11L is a 1065 base pairs (354 aminoacids) gene expressed early during infection with no attributed function. The F11L gene is conserved in many but not all poxviruses. The essential presence of the F11L gene was tested using two different genetic methods. F11L gene disruption by insertion of a selectable cassette containing the Escherichia coli guanine phosphoribosyl transferase gene driven by the viral early-late 7.5K transcriptional promoter resulted exclusively in recombinant viruses containing both the wild type and disrupted alleles, indicating that the F11L gene was essential. However, an alternative test, using transient dominant selection to insert nonsense mutations into the F11L gene, proved that the F11L gene was non-essential for growth in culture. These experiments suggest that misleading results can be obtained using gene insertional mutagenesis as a test of essential presence of the gene. The experiments also provide genetic data on the probability of co-insertion of linked mutations in vaccinia virus genome using transient dominant selection.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14656458     DOI: 10.1016/j.jviromet.2003.09.011

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  8 in total

1.  Phenotypic analysis of a temperature sensitive mutant in the large subunit of the vaccinia virus mRNA capping enzyme.

Authors:  Amber N Shatzer; Sayuri E M Kato; Richard C Condit
Journal:  Virology       Date:  2008-03-04       Impact factor: 3.616

2.  A novel mode of poxvirus superinfection exclusion that prevents fusion of the lipid bilayers of viral and cellular membranes.

Authors:  Jason P Laliberte; Bernard Moss
Journal:  J Virol       Date:  2014-06-11       Impact factor: 5.103

3.  Vaccinia virus A6L encodes a virion core protein required for formation of mature virion.

Authors:  Xiangzhi Meng; Addie Embry; Debbi Sochia; Yan Xiang
Journal:  J Virol       Date:  2006-11-15       Impact factor: 5.103

4.  Modulation of the myxoma virus plaque phenotype by vaccinia virus protein F11.

Authors:  Chad R Irwin; David H Evans
Journal:  J Virol       Date:  2012-04-18       Impact factor: 5.103

5.  The vaccinia virus E8R gene product is required for formation of transcriptionally active virions.

Authors:  Sayuri E M Kato; Richard C Condit; Nissin Moussatché
Journal:  Virology       Date:  2007-07-09       Impact factor: 3.616

6.  Myxoma virus oncolytic efficiency can be enhanced through chemical or genetic disruption of the actin cytoskeleton.

Authors:  Chad R Irwin; Nicole A Favis; Kate C Agopsowicz; Mary M Hitt; David H Evans
Journal:  PLoS One       Date:  2013-12-31       Impact factor: 3.240

7.  F11-mediated inhibition of RhoA signalling enhances the spread of vaccinia virus in vitro and in vivo in an intranasal mouse model of infection.

Authors:  João V Cordeiro; Susana Guerra; Yoshiki Arakawa; Mark P Dodding; Mariano Esteban; Michael Way
Journal:  PLoS One       Date:  2009-12-30       Impact factor: 3.240

8.  Detection of myxoma viruses encoding a defective M135R gene from clinical cases of myxomatosis; possible implications for the role of the M135R protein as a virulence factor.

Authors:  Graham J Belsham; Charlotta Polacek; Solvej Ø Breum; Lars E Larsen; Anette Bøtner
Journal:  Virol J       Date:  2010-01-16       Impact factor: 4.099

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.